These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1342 related items for PubMed ID: 23128923

  • 21. Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.
    El Marroun H, White TJ, Fernandez G, Jaddoe VW, Verhulst FC, Stricker BH, Tiemeier H.
    J Psychopharmacol; 2017 Mar; 31(3):346-355. PubMed ID: 27624153
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG, Cold JA, Jann MW.
    Pharmacotherapy; 1997 Mar; 17(3):511-30. PubMed ID: 9165554
    [Abstract] [Full Text] [Related]

  • 24. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 27. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
    Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M.
    J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
    [Abstract] [Full Text] [Related]

  • 28. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
    Shea ML, Garfield LD, Teitelbaum S, Civitelli R, Mulsant BH, Reynolds CF, Dixon D, Doré P, Lenze EJ.
    Osteoporos Int; 2013 May; 24(5):1741-9. PubMed ID: 23358607
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hyponatremia with venlafaxine.
    Masood GR, Karki SD, Patterson WR.
    Ann Pharmacother; 1998 Jan; 32(1):49-51. PubMed ID: 9475820
    [Abstract] [Full Text] [Related]

  • 31. SSRI antidepressants and persistent pulmonary hypertension in newborns.
    Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
    [Abstract] [Full Text] [Related]

  • 32. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A, Zhao JP, Sheehy O.
    BMJ Open; 2017 Jan 12; 7(1):e013372. PubMed ID: 28082367
    [Abstract] [Full Text] [Related]

  • 33. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr 12; 259(3):172-85. PubMed ID: 19165525
    [Abstract] [Full Text] [Related]

  • 34. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
    Anderson KN, Lind JN, Simeone RM, Bobo WV, Mitchell AA, Riehle-Colarusso T, Polen KN, Reefhuis J.
    JAMA Psychiatry; 2020 Dec 01; 77(12):1246-1255. PubMed ID: 32777011
    [Abstract] [Full Text] [Related]

  • 35. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
    Stahl SM, Entsuah R, Rudolph RL.
    Biol Psychiatry; 2002 Dec 15; 52(12):1166-74. PubMed ID: 12488062
    [Abstract] [Full Text] [Related]

  • 36. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
    Griffiths RI, Sullivan EM, Frank RG, Strauss MJ, Herbert RJ, Clouse J, Goldman HH.
    Pharmacoeconomics; 1999 May 15; 15(5):495-505. PubMed ID: 10537966
    [Abstract] [Full Text] [Related]

  • 37. Does fetal exposure to SSRIs or maternal depression impact infant growth?
    Wisner KL, Bogen DL, Sit D, McShea M, Hughes C, Rizzo D, Confer A, Luther J, Eng H, Wisniewski SW.
    Am J Psychiatry; 2013 May 15; 170(5):485-93. PubMed ID: 23511234
    [Abstract] [Full Text] [Related]

  • 38. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR, Huang H, Thase ME.
    J Clin Psychiatry; 2001 Nov 15; 62(11):869-77. PubMed ID: 11775046
    [Abstract] [Full Text] [Related]

  • 39. Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome.
    Koren G, Moretti M, Kapur B.
    J Obstet Gynaecol Can; 2006 Apr 15; 28(4):299-301. PubMed ID: 16776907
    [Abstract] [Full Text] [Related]

  • 40. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL, O'Grady KE, Battle CL, Wisner KL, Anderson GM, Stroud LR, Miller-Loncar CL, Young ME, Lester BM.
    Am J Psychiatry; 2016 Feb 01; 173(2):147-57. PubMed ID: 26514656
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 68.